4.6 Article

Suppression of Hepatic PPARα in Primary Biliary Cholangitis Is Modulated by miR-155

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis

Diego Saenz de Urturi et al.

Summary: Altered methionine metabolism is associated with weight gain in obesity. In this study, the authors demonstrate that inhibiting methionine adenosyltransferase has beneficial effects in preventing and reversing obesity, insulin resistance, and fatty liver. This is achieved by increasing energy expenditure and FGF21 secretion.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

DHEA Protects Human Cholangiocytes and Hepatocytes against Apoptosis and Oxidative Stress

Ewa Kilanczyk et al.

Summary: Primary biliary cholangitis (PBC) is a chronic liver disease that primarily affects postmenopausal women. This study found that DHEA and its metabolites can enhance the proliferation of cholangiocytes and hepatocytes and delay the onset of the disease.

CELLS (2022)

Article Endocrinology & Metabolism

The role of peroxisome proliferator-activated receptors (PPAR) in immune responses

Anthos Christofides et al.

Summary: PPARs are fatty acid-activated transcription factors that regulate energy metabolism, with three subtypes identified: PPAR alpha, PPAR gamma, and PPAR beta/delta. They play distinct roles in oxidative and adipose tissues, as well as in immune cells, contributing to immune cell differentiation and inflammation.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Article Gastroenterology & Hepatology

Bezafibrate therapy in primary biliary cholangitis refractory to ursodeoxycholic acid: a longitudinal study of paired liver biopsies at 5 years of follow up

Juan Antonio Sorda et al.

Summary: Adding bezafibrate to UDCA in patients with UDCA-refractory PBC significantly decreased fibrosis and inflammatory histological scores at 5 years, suggesting potential long-term benefits in cohort studies and controlled trials.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Article Gastroenterology & Hepatology

A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA

Jorn M. Schattenberg et al.

Summary: Elafibranor demonstrated good efficacy and safety in patients with PBC who had an incomplete response to ursodeoxycholic acid, significantly reducing levels of ALP and improving other disease activity markers.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Safety of fibrates in cholestatic liver diseases

Andres F. Carrion et al.

Summary: Fibrates are safe and well tolerated in patients with primary biliary cholangitis, with gastrointestinal and musculoskeletal adverse events being most commonly reported. Data on the safety of these agents for treatment of primary sclerosing cholangitis are limited.

LIVER INTERNATIONAL (2021)

Article Gastroenterology & Hepatology

Adjunct Fenofibrate Up-regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis

Gina M. Gallucci et al.

Summary: This study investigated the efficacy of adjunct fenofibrate therapy in up-regulating BA-glucuronidation and reducing serum BA toxicity during cholestasis. The results showed that combination therapy significantly decreased serum ALP levels and favorably altered major serum BA-glucuronides.

HEPATOLOGY COMMUNICATIONS (2021)

Article Medicine, General & Internal

Primary biliary cholangitis

Ana Lleo et al.

LANCET (2020)

Article Gastroenterology & Hepatology

Knockout of microRNA-21 attenuates alcoholic hepatitis through th VHL/NF-κB signaling pathway in hepatic stellate cells

Nan Wu et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)

Article Biochemistry & Molecular Biology

A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular Carcinoma

Aaron Balasingam Koenig et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Biochemistry & Molecular Biology

miRNA-21 ablation protects against liver injury and necroptosis in cholestasis

Marta B. Afonso et al.

CELL DEATH AND DIFFERENTIATION (2018)

Article Biochemistry & Molecular Biology

Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway

Agnieszka Kempinska-Podhorodecka et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Multidisciplinary Sciences

PPARα activation protects against cholestatic liver injury

Qi Zhao et al.

SCIENTIFIC REPORTS (2017)

Article Medicine, Research & Experimental

Macrophage deficiency of miR-21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis

Alberto Canfran-Duque et al.

EMBO MOLECULAR MEDICINE (2017)

Article Cell Biology

Anti-inflammatory effects of miR-21 in the macrophage response to peritonitis

Rebecca Elise Barnett et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2016)

Editorial Material Gastroenterology & Hepatology

Tiny RNA with great effects: miR-155 in alcoholic liver disease

Phillipp Hartmann et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis

Shashi Bala et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Fibrates and cholestasis

Nisanne S. Ghonem et al.

HEPATOLOGY (2015)

Review Immunology

Physiological roles of miR-155

Ryuichi Mashima

IMMUNOLOGY (2015)

Article Gastroenterology & Hepatology

Fenofibrate is effective adjunctive therapy in the treatment of primary biliary cirrhosis: A meta-analysis

Alla Y. Grigorian et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)

Article Multidisciplinary Sciences

Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocelular apoptosis

Pedro M. Rodrigues et al.

SCIENTIFIC REPORTS (2015)

Review Immunology

Turning 21: induction of miR-21 as a key swith in the inflammatory response

Frederick J. Sheedy

FRONTIERS IN IMMUNOLOGY (2015)

Letter Gastroenterology & Hepatology

Letter: apoptosis and hepatic fibrosis in chronic hepatitis B - authors' reply

R. J. Longchamps et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)

Review Gastroenterology & Hepatology

MicroRNAs in liver disease

Gyongyi Szabo et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)

Article Multidisciplinary Sciences

Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction

Yang Hu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Biochemistry & Molecular Biology

Metabolomics reveals an essential role for peroxisome proliferator-activated receptor α in bile acid homeostasis

Fei Li et al.

JOURNAL OF LIPID RESEARCH (2012)

Article Medicine, Research & Experimental

Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection

Shashi Bala et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2012)

Article Chemistry, Multidisciplinary

PPARα Is Regulated by miR-21 and miR-27b in Human Liver

Katsuhiko Kida et al.

PHARMACEUTICAL RESEARCH (2011)

Article Multidisciplinary Sciences

MicroRNA-21 targets peroxisome proliferators-activated receptor-α in an autoregulatory loop to modulate flow-induced endothelial inflammation

Jing Zhou et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Biochemistry & Molecular Biology

Signaling by the Matrix Proteoglycan Decorin Controls Inflammation and Cancer Through PDCD4 and MicroRNA-21

Rosetta Merline et al.

SCIENCE SIGNALING (2011)

Article Gastroenterology & Hepatology

Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid

Rui E. Castro et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)

Article Gastroenterology & Hepatology

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

Christophe Corpechot et al.

HEPATOLOGY (2008)